OncoCyte Corp (OCX)
2.99
-0.08
(-2.61%)
USD |
NASDAQ |
May 17, 16:00
2.99
0.00 (0.00%)
After-Hours: 20:00
OncoCyte Cash from Financing (Quarterly): -0.03M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.03M |
| September 30, 2023 | -0.03M |
| June 30, 2023 | 12.27M |
| March 31, 2023 | -0.028M |
| December 31, 2022 | -0.10M |
| September 30, 2022 | -0.528M |
| June 30, 2022 | 36.79M |
| March 31, 2022 | -0.355M |
| December 31, 2021 | -0.269M |
| September 30, 2021 | 8.215M |
| June 30, 2021 | 0.547M |
| March 31, 2021 | 69.87M |
| December 31, 2020 | 3.493M |
| September 30, 2020 | 0.028M |
| June 30, 2020 | 11.71M |
| March 31, 2020 | 7.565M |
| December 31, 2019 | 10.85M |
| September 30, 2019 | -0.296M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.58M |
| March 31, 2019 | 37.89M |
| December 31, 2018 | -0.331M |
| September 30, 2018 | 3.019M |
| June 30, 2018 | 1.656M |
| March 31, 2018 | 7.77M |
| December 31, 2017 | -0.074M |
| September 30, 2017 | 5.88M |
| June 30, 2017 | 0.18M |
| March 31, 2017 | 3.982M |
| December 31, 2016 | 0.122M |
| September 30, 2016 | 9.717M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.042M |
| December 31, 2015 | -0.001M |
| September 30, 2015 | 8.354M |
| June 30, 2015 | 3.30M |
| March 31, 2015 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.58M
Minimum
Jun 2019
69.87M
Maximum
Mar 2021
8.375M
Average
0.028M
Median
Sep 2020
Cash from Financing (Quarterly) Benchmarks
| Fonar Corp | -1.761M |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 2.271M |
| Applied DNA Sciences Inc | 3.015M |
| Veracyte Inc | -0.864M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.562M |
| Cash from Investing (Quarterly) | 0.241M |
| Free Cash Flow | -23.61M |
| Free Cash Flow Per Share (Quarterly) | -0.5838 |
| Free Cash Flow to Equity (Quarterly) | -4.826M |
| Free Cash Flow Yield | -105.4% |